Cullinan Oncology LLC
Price & Volume
Stats
See more52W Range | $5.89-$18.40 |
Market Cap | $366.2M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $18.9M |
Diluted EPS | -$3.16 |
News
See moreYahoo Finance • 11 days ago
Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum
Yahoo Finance • last month
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance • 2 months ago
Cullinan Therapeutics GAAP EPS of -$1.07
Yahoo Finance • 2 months ago
CULLINAN THERAPEUTICS INC (NASDAQ:CGEM) Reports Wider Q2 2025 Loss, Misses EPS Estimates Amid Rising R&D Costs
About
CEO | Mr. Nadim Ahmed |
Address | One Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 111 |
